Autoimmune Diseases  >>  Adlyxin (lixisenatide)  >>  Phase 1
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove FilterRemove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Adlyxin (lixisenatide) / Sanofi
NCT01146678: Relative Bioavailability and Activity of Different Formulations of Insulin Glargine and Lixisenatide in Patients With Diabetes Mellitus Type 1

Completed
1
22
Europe
Insulin glargine HOE901, Lixisenatide AVE0010
Sanofi
Type 1 Diabetes Mellitus
09/10
01/11

Download Options